A wax ester and astaxanthin-rich extract from the marine copepod Calanus finmarchicus attenuates atherogenesis in female apolipoprotein E-deficient mice

Journal of Nutrition

Volumn 142, Issue 3, 2012, Pages 508-512

  Eilertsen, Karl Erik ^a   Mæhre, Hanne K ^a   Jensen, Ida J ^a   Devold, Hege ^a   Olsen, Jan Ole ^a   Lie, Reidun K ^a   Brox, Jan ^b   Berg, Vivian ^b   Elvevoll, Edel O ^a   Østerud, Bjarne ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CALANUS OIL; CHOLESTEROL; COLONY STIMULATING FACTOR 1; CORN OIL; CXCL1 CHEMOKINE; ESTER; HERBACEOUS AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LL1B PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NFKB1 PROTEIN; PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; WAX;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; CALANUS FINMARCHICUS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COPEPOD; DIET SUPPLEMENTATION; FEMALE; GENE EXPRESSION; LIPID DIET; MOUSE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; AORTA, THORACIC; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; COPEPODA; CYTOKINES; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FATTY ACIDS; FEMALE; GENE EXPRESSION; GROWTH SUBSTANCES; LIVER; MICE; MICE, KNOCKOUT; TRIGLYCERIDES; ZOOPLANKTON;

CALANUS; CALANUS FINMARCHICUS; COPEPODA; MUS; ZEA MAYS;

EID: 84858259468     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.145698     Document Type: Article

References (42)

1. Zampolli A, Bysted A, Leth T, Mortensen A, De Caterina R, Falk E. Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. Atherosclerosis. 2006;184:78-85.
2. Gigliotti JC, DavenportMP, Beamer SK, Tou JC, Jaczynski J. Extraction and characterisation of lipids from Antarctic krill (Euphausia superba). Food Chem. 2011;125:1028-36.
3. Skjoldal H, Sætre R, Færnö A, Misund O, Røttingen I, editors. The Norwegian Sea ecosystem. Trondheim (Norway): Tapir Academic Press; 2004.
4. Larsen R, Eilertsen KE, Elvevoll EO. Health benefits of marine foods and ingredients. Biotechnol Adv. 2011;29:508-18.
5. Graeve M, Kattner G. Species-specific differences in intact wax esters of Calanus-hyperboreus and C-finmarchicus from Fram Strait - Greenland Sea. Mar Chem. 1992;39:269-81.
6. Bogevik A. Marine wax ester digestion in salmonid fish: a review. Aquac Res. 2011;42:1577-93.
7. Kattner G, HagenW. Polar herbivorous copepods: different pathways in lipid biosynthesis. ICES J Mar Sci. 1995;52:329-35.
8. Whelan J. Dietary stearidonic acid is a long chain (n-3) polyunsaturated fatty acid with potential health benefits. J Nutr. 2009;139:5-10.
9. Horia E, Watkins BA. Comparison of stearidonic acid and alphalinolenic acid on PGE(2) production and COX-2 protein levels in MDAMB-231 breast cancer cell cultures. J Nutr Biochem. 2005;16:184-92.
10. GuichardantM, Traitler H, Spielmann D, Sprecher H, Finot PA. Stearidonic acid, an inhibitor of the 5-lipoxygenase pathway: a comparison with timnodonic and dihomogammalinolenic acid. Lipids. 1993;28:321-4.
11. Kockmann V, Spielmann D, Traitler H, Lagarde M. Inhibitory effect of stearidonic acid (18-4 N-3) on platelet-aggregation and arachidonate oxygenation. Lipids. 1989;24:1004-7.
12. Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;101:D58-68.
13. Jacobsson LS, Yuan XM, Ziedén B, Olsson AG. Effects of A-tocopherol and astaxanthin on plasma lipids, LDL oxidation and atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis. 1999;144:56-7.
14. Jacobsson LS, Yuan XM, Zieden B, Olsson AG. Effects of alphatocopherol and astaxanthin on LDL oxidation and atherosclerosis in WHHL rabbits. Atherosclerosis. 2004;173:231-7.
15. Yang Y, Seo JM, Nguyen A, Pham TX, Park HJ, Park Y, Kim B, Bruno RS, Lee J. Astaxanthin-rich extract from the green alga haematococcus pluvialis lowers plasma lipid concentrations and enhances antioxidant defense in apolipoprotein E knockout mice. J Nutr. 2011;141:1611-7.
16. Plump AS, Smith JD, Hayek T, Aaltosetala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein-E-deficient mice created by homologous recombination in es cells. Cell. 1992;71:343-53.
17. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein-E. Science. 1992;258:468-71.
18. Horwitz W, editor. Official methods of analysis of AOAC International. Gaithersburg: AOAC International; 2005.
19. Firestone D, editor. Official methods and recommended practices of the AOCS. 6th ed. Champaign (IL): American Oil Chemists Society; 2009.
20. Elvevoll EO, Barstad H, Breimo ES, Brox J, Eilertsen KE, Lund T, Olsen JO, Osterud B. Enhanced incorporation of n-3 fatty acids from fish compared with fish oils. Lipids. 2006;41:1109-14.
21. Moore S, Stein WH. Chromatographic determination of amino acids by the use of automatic recording equipment. Methods Enzymol. 1963;6:819-31.
22. Eilertsen K-E, Maehre H, Cludts K, Olsen JO, Hoyalerts M. Dietary enrichment of apolipoprotein E-deficient mice with extra virgin olive oil in combination with seal oil inhibits atherogenesis. Lipids Health Dis. 2011;10:41.
23. Rasband WS, Image J. U.S. NIH, Bethesda, MD; 2009 [cited 2011 Dec 7]. Available from: http://rsb.info.nih.gov/ij/.
24. Marangoni F, Colombo C, Galli C. A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies. Anal Biochem. 2004;326:267-72.
25. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36.
26. Letters JM, Witting PK, Christison JK, Eriksson AW, Pettersson K, Stocker R. Time-dependent changes to lipids and antioxidants in plasma and aortas of apolipoprotein E knockout mice. J Lipid Res. 1999;40:1104-12.
27. Thomas SR, Leichtweis SB, Pettersson K, Croft KD, Mori TA, Brown AJ, Stocker R. Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol. 2001;21:585-93.
28. Bakker GCM, van Erk MJ, Pellis L, Wopereis S, Rubingh CM, Cnubben NHP, Kooistra T, van Ommen B, Hendriks HFJ. An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am J Clin Nutr. 2010;91:1044-59.
29. Verschuren L, Wielinga PY, van Duyvenvoorde W, Tijani S, Toet K, van Ommen B, Kooistra T, Kleemann R. A dietary mixture containing fish oil, resveratrol, lycopene, catechins, and vitamins E and C reduces atherosclerosis in transgenic mice. J Nutr. 2011;141:863-9.
30. Connor WE, Rohwedder JJ, Hoak JC. Production of hypercholesterolemia and atherosclerosis by a diet rich in shellfish. J Nutr. 1963;79: 443-50.
31. Maki KC, Reeves MS, Farmer M, Griinari M, Berge K, Vik H, Hubacher R, Rains TM. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res. 2009;29:609-15.
32. Tandy S, Chung RWS, Wat E, Kamili A, Berge K, Griinari M, Cohn JS. Dietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high-fat-fed mice. J Agric Food Chem. 2009;57:9339-45.
33. Ulven S, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, Berge K, Vik H, Pedersen J. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids. 2011;46:37-46.
34. IernaM, Kerr A, Scales H, Berge K, Griinari M. Supplementation of diet with krill oil protects against experimental rheumatoid arthritis. BMC Musculoskelet Disord. 2010;11:136-46.
35. Di Marzo V, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L, Giordano E, Bisogno T, Collu M, Batetta B, et al. Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. Int Dairy J. 2010;20:231-5.
36. Bridges KM, Gigliotti JC, Altman S, Jaczynski J, Tou JC. Determination of digestibility, tissue deposition, and metabolism of the omega-3 fatty acid content of krill protein concentrate in growing rats. J Agric Food Chem. 2010;58:2830-7.
37. Mills SC, Windsor AC, Knight SC. The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes. Clin Exp Immunol. 2005;142:216-28.
38. Sargent JR, Gatten RR. The distribution and metabolism of wax esters in marine invertebrates. Biochem Soc Trans. 1976;4:431-3.
39. Gillingham LG, Harris-Janz S, Jones PJH. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids. 2011;46:209-28.
40. Lindström MB, Sternby B, Borgstrom B. Concerted action of human carboxyl ester lipase and pancreatic lipase during lipid digestion in vitro: importance of the physicochemical state of the substrate. Biochim Biophys Acta. 1988;959:178-84.
41. Hui DY, Howles PN. Carboxyl ester lipase: structure-function relationship and physiological role in lipoprotein metabolism and atherosclerosis. J Lipid Res. 2002;43:2017-30.
42. Hargrove JL, Greenspan P, Hartle DK. Nutritional significance and metabolism of very long chain fatty alcohols and acids from dietary waxes. Exp Biol Med (Maywood). 2004;229:215-26.